Ledger.Open graph →
SEC Form D · filed December 18, 2017

AZTherapies, INC

Offering
$6.0M
Sold
$1.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

David S. Taft · Boston, MADirectorRonald S. Tompkins · Boston, MADirectorJohn S. Porter · Boston, MADirectorKeith S. Greenfield · Boston, MAExec · DirectorDavid R. Elmaleh · Boston, MAExec · DirectorPeter S. Conti · Boston, MADirectorRobert S. Warren · Boston, MAExecCary B. Marr · Grand Cayman, Cayman IslandsDirectorSergei Nodelman · New York, NYExec · DirectorRon A. Nelson · St. Louis Park, MNDirectorStephen Quin · Vancouver, British Columbia, CanadaExecIvana B. Faltysova · Grand Cayman, Cayman IslandsExec · DirectorDavid H. Chung · St. Louis Park, MNDirectorAndrew K. Elbardissi · St. Louis Park, MNDirectorDon Guthrie · Seattle, WAExec · DirectorA. Daniel Greenshield · Seattle, WAExecWilliam Bennett · Vancouver, British Columbia, CanadaDirectorGeoff Entress · Seattle, WAExec · DirectorSean Glass · Arlington, VADirectorRichard Foster · Arlington, VADirectorGurinder Ahluwalia · SAN FRANCISCO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗